Health Subcommittee Advances Public Health Reauthorizations and Policies to Improve FDA and Medicare to Full Committee
WASHINGTON, D.C. – Today, Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, led a markup of public health reauthorization bills, as well as bills that strengthen FDA oversight and improve Medicare outcomes for both patients and providers.
“The legislation considered today reflects this Subcommittee’s efforts to improve public health outcomes, enhance patient access, and modernize our health care delivery system to better meet the challenges Americans face. These bills represent thoughtful efforts from members on both sides of the aisle,” said Chairman Griffith. “I am encouraged by the collaborative work that has gone into this legislation, and I look forward to bringing them to the full Committee.”
Legislative Vote Summary:
• H.R. 4348, To reauthorize the Kay Hagan Tick Act, and for other purposes, was reported to the full committee by a voice vote.
• H.R. 4541, EARLY Act Reauthorization of 2025, was reported to the full committee by a voice vote.
• H.R. 3747, Accelerating Access to Dementia and Alzheimer’s Provider Training (AADAPT) Act, was reported to the full committee by a voice vote.
• H.R. 8209, School-Based Health Centers Reauthorization Act of 2026, was reported to the full committee by a voice vote.
• H.R. 5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025, was reported to the full committee by a voice vote.
• H.R. 8205, Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026, was reported to the full committee by a voice vote.
• H.R. 2715, Destruction of Hazardous Imports Act, was reported to the full committee by a voice vote.
• H.R. 2821, FDA Modernization Act 3.0, was reported to the full committee by a voice vote.
• H.R. 5347, Health Care Efficiency Through Flexibility Act, was reported to the full committee by a voice vote.
• H.R. 1703, Choices for Increased Mobility Act of 2025, was reported to the full committee by a voice vote.
Watch the full markup here.
Below are key excerpts from today’s markup:
Congressman Buddy Carter (GA-01), on H.R. 2821, the FDA Modernization Act 3.0: “In 2022, I was proud to help lead passage of the FDA Modernization Act 2.0—which, for the first time, allowed drug developers to use modern, animal-free testing methods as alternatives to traditional animal testing. Congress made its intent clear: we wanted to reduce outdated testing requirements and encourage more effective, humane, and innovative approaches to drug development. Unfortunately, the Biden Administration failed to fully implement that law, limiting its effectiveness and leaving too many animals still at risk. That is why I introduced the FDA Modernization Act 3.0. This legislation ensures that the FDA finally carries out the will of Congress and the American people by fully embracing modern alternatives to animal testing. This bill will help reduce and replace the use of animals in non-clinical research, while also improving the efficiency of the drug development process and helping bring lifesaving treatments to patients faster.”
Congressman John Joyce, M.D. (PA-13), on H.R. 1703, the Choices for Increased Mobility Act of 2025: “In 2016, the Durable Medical Equipment Medicare Administration Contractors issued a policy that severely limited access to titanium and carbon fiber wheelchairs by preventing the billing of the existing code and allowing the beneficiary to cover the difference of the upgrades. As a result, the only way to obtain a titanium or carbon fiber wheelchair is to pay the entire cost out of pocket by the patient wishing to choose that chair. This is cost-prohibitive for the many beneficiaries and has detrimental effects on access to titanium and carbon fiber wheelchairs. This not only affects the patient—it affects their families who help them, who lift those wheelchairs; it affects their caregivers who push and utilize these heavier wheelchairs. This subcommittee should be encouraging Medicare patients to take full advantage of their health care benefits, and more importantly, giving them a say in the choice that will directly impact their quality of life. This bipartisan legislation will remove the barrier that, since, unfortunately, 2016, has impeded access to lightweight, durable medical equipment for individuals who live day-to-day with mobility impairments.”
Congressman Troy Balderson (OH-12), on H.R. 3747, the Accelerating Access to Dementia and Alzheimer’s Provider Training (AADAPT) Act: “Today, more than 7 million Americans, including more than 236,000 Ohioans, are living with Alzheimer's disease. As these numbers continue to rise, we need stronger provider training and better access to community-based dementia care so families can get answers sooner and connect to care earlier. The AADAPT Act helps give primary care providers the resources they need to help families get that diagnosis sooner. In rural communities, access to specialists is often limited, and for many families, their primary care provider is the first—and sometimes only—point of contact when cognitive decline begins to appear. Yet, too many frontline providers report they do not have the training tools or support they need to confidently identify and manage dementia-related conditions. As a result, far too many Americans are diagnosed later than they should be, after valuable time for treatment and planning has already been lost.”